Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionSandler Capital Management
Latest Disclosed Ownership17,936 shares
Latest Disclosed Value $ 937,335
Sandler Capital Management ownership in TECH / Bio-Techne Corporation

On May 15, 2026 - Sandler Capital Management filed a 13F-HR form disclosing ownership of 17,936 shares of Bio-Techne Corporation (US:TECH) valued at $937,335 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 15,443 shares of Bio-Techne Corporation. This represents a change in shares of 16.14% during the quarter. The current value of the position is $912,046 USD.

Sandler Capital Management has a history of taking positions in derivatives of the underlying security (TECH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TECH / Bio-Techne Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIO-TECHNE COM 09073M104 17,936 2,493 16.14 937 3.19 0.4853
2026-02-17 2025-12-31 13F BIO-TECHNE COM 09073M104 15,443 15,443 908 0.2975
2025-08-14 2025-06-30 13F BIO-TECHNE COM 09073M104 0 -27,020 -100.00 0 -100.00
2025-05-15 2025-03-31 13F BIO-TECHNE COM 09073M104 27,020 27,020 1,584 0.3965
2025-02-14 2024-12-31 13F BIO-TECHNE COM 09073M104 0 -15,493 -100.00 0 -100.00
2024-11-14 2024-09-30 13F BIO-TECHNE COM 09073M104 15,493 -42,759 -73.40 1,238 -70.33 0.1636
2024-08-14 2024-06-30 13F BIO-TECHNE COM 09073M104 58,252 12,570 27.52 4,174 29.80 0.4472
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 45,682 -20,530 -31.01 3,216 -37.06 0.2345
2024-02-14 2023-12-31 13F BIO-TECHNE COM 09073M104 66,212 -91,895 -58.12 5,109 -52.54 0.4234
2023-11-14 2023-09-30 13F BIO-TECHNE COM 09073M104 158,107 93,873 146.14 10,762 105.26 1.1083
2023-08-14 2023-06-30 13F BIO-TECHNE COM 09073M104 64,234 -20,051 -23.79 5,243 -16.15 0.4317
2023-05-15 2023-03-31 13F BIO-TECHNE COM 09073M104 84,285 -86,995 -50.79 6,253 -55.95 0.5699
2023-02-14 2022-12-31 13F BIO-TECHNE COM 09073M104 171,280 150,493 723.98 14,196 140.43 1.4549
2022-11-14 2022-09-30 13F BIO-TECHNECORP COM 09073M104 20,787 97 0.47 5,904 -17.68 0.8238
2022-08-15 2022-06-30 13F BIO-TECHNE COM 09073M104 20,690 -140 -0.67 7,172 -20.49 0.7609
2022-05-16 2022-03-31 13F BIO-TECHNE COM 09073M104 20,830 -41,100 -66.37 9,020 -71.85 0.7955
2022-02-14 2021-12-31 13F BIO-TECHNE COM 09073M104 61,930 -6,717 -9.78 32,039 -3.68 2.7730
2021-11-15 2021-09-30 13F BIO-TECHNE COM 09073M104 68,647 -3,560 -4.93 33,264 2.31 2.9494
2021-08-16 2021-06-30 13F BIO-TECHNE COM 09073M104 72,207 -4,913 -6.37 32,512 10.38 2.5380
2021-05-17 2021-03-31 13F BIO-TECHNE COM 09073M104 77,120 28,480 58.55 29,454 90.69 2.5134
2021-02-16 2020-12-31 13F BIO-TECHNE COM 09073M104 48,640 8,400 20.87 15,446 54.94 1.8061
2020-11-16 2020-09-30 13F BIO-TECHNE COM 09073M104 40,240 -22,160 -35.51 9,969 -39.50 1.0020
2020-08-14 2020-06-30 13F BIO-TECHNE COM 09073M104 62,400 -3,341 -5.08 16,478 32.18 1.5683
2020-05-15 2020-03-31 13F BIO-TECHNE COM 09073M104 65,741 5,630 9.37 12,466 -5.52 1.7236
2020-02-14 2019-12-31 13F BIO TECHNE COM 09073M104 60,111 16,766 38.68 13,195 55.58 1.5144
2019-11-14 2019-09-30 13F BIO TECHNE COM 09073M104 43,345 -8,611 -16.57 8,481 -21.70 0.7426
2019-08-14 2019-06-30 13F BIO TECHNE COM 09073M104 51,956 11,186 27.44 10,832 33.81 0.7237
2019-05-15 2019-03-31 13F BIO TECHNE COM 09073M104 40,770 40,770 8,095 0.6298
2019-02-14 2018-12-31 13F BIO TECHNE COM 09073M104 0 -39,110 -100.00 0 -100.00
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 39,110 -10,960 -21.89 7,983 7.76 0.4031
2018-08-14 2018-06-30 13F BIO TECHNE COM 09073M104 50,070 -41,982 -45.61 7,408 -46.72 0.6193
2018-05-15 2018-03-31 13F BIO TECHNE COM 09073M104 92,052 21,690 30.83 13,904 52.54 1.6983
2018-02-14 2017-12-31 13F BIO TECHNE COM 09073M104 70,362 -10,198 -12.66 9,115 -6.41 1.2828
2017-11-14 2017-09-30 13F BIO TECHNE COM 09073M104 80,560 7,550 10.34 9,739 13.52 1.2124
2017-08-14 2017-06-30 13F BIO TECHNE COM 09073M104 73,010 73,010 8,579 0.9309
2017-05-15 2017-03-31 13F BIO TECHNE COM 09073M104 0 -51,815 -100.00 0 -100.00
2017-02-14 2016-12-31 13F BIO TECHNE COM 09073M104 51,815 -27,385 -34.58 5,328 -38.56 0.4779
2016-11-14 2016-09-30 13F BIO TECHNE COM 09073M104 79,200 15,760 24.84 8,672 21.22 1.0648
2016-08-15 2016-06-30 13F BIO TECHNE COM 09073M104 63,440 63,440 7,154 0.9436
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F BIO-TECHNE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F BIO-TECHNE COM Call 39,500 -16.49 2,197 -9.70 n/a n/a n/a
2025-08-14 2025-06-30 13F BIO-TECHNE COM Call 47,300 2,434 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.